Les cancers viro-induits: interrelations genetique-environnement

[en] Among cancers diagnosed worldwide on a yearly basis, 20% are thought to be associated with a viral infection. The viruses involved are, by order of decreasing incidence, the hepatitis viruses, the papillomaviruses and the Epstein-Barr virus. These virus-induced cancers generate a high level of interest not only for the study of mechanisms involved in the neoplastic transformation, but also for the set-up of specific immunotherapies including prophylactic and therapeutic antitumor vaccination.

Disciplines :

Dermatology

Author, co-author :

Delvenne, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques

Renoux, Virginie

Arafa, M.

Trimeche, M.

Christophe, J.

Kridelka, Frédéric ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie et obstétrique

PIERARD, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

French

Title :

Les cancers viro-induits: interrelations genetique-environnement

Alternative titles :

[en] Virus-induced cancers: interplay between genetics and environment

Publication date :

2012

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

5-6

Pages :

381-9

Peer reviewed :

Peer reviewed

Available on ORBi :

since 08 October 2012

Statistics

Number of views

197 (5 by ULiège)

Number of downloads

3157 (13 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Delvenne P, Hubert P, Jacobs N, et al. - The organotypic culture of HPV-transformed keratinocytes : an effective in vitro model for the development of new immunotherapeutic approaches for mucosal (pre)neoplastic lesions. Vaccine, 2001, 19, 2557-2564. (Pubitemid 32234272)
Manna CD, Neala CP, Garceab G, et al. - Prognostic molecular markers in hepatocellular carcinoma : a systematic review. Eur J Cancer, 2007, 43, 979-992.
Capocaccia R, Sant M, Berrino F, et al. - Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol, 2007, 102, 1661-1670.
Park NH, Chung YH. - Molecular mechanisms of hepatitis B virus-associated hepatocellular carcinoma. Korean J Hepatol, 2007, 13, 320-340.
Tsai WL, Chung RT. - Viral hepatocarcinogenesis. Oncogene, 2010, 29, 2309-2324.
Huang H, Shiffman ML, Cheung RC, et al. - Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology, 2006, 130, 1679-1687. (Pubitemid 43668836)
Yuen MF, Lai CL. - Screening for hepatocellular carcinoma : survival benefit and cost-effectiveness. Ann Oncol, 2003, 14, 1463-1467.
Johnson PJ. - The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis, 2001, 5, 145-159. (Pubitemid 32118643)
Di Bisceglie AM. - Hepatitis B and hepatocellular carcinoma. Hepatology, 2009, 49, S56-S60.
Llovet JM. - Updated treatment approach to hepatocellular carcinoma. J Gastroenterol, 2005, 40, 225-235. (Pubitemid 40613379)
Lopez LJ, Marrero JA. - Hepatocellular carcinoma. Curr Opin Gastroenterol, 2004, 20, 248-253.
Ferlay J, Shin HR, Bray F, et al. - Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008. Int J Cancer, 2010, 127, 2893-2917.
zur Hausen H, Gissmann L, Steiner W, et al. - Human papilloma viruses and cancer. Bibl Haematol, 1975, 43, 569-571.
Bernard HU, Burk RD, Chen Z, et al. - Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology, 2010, 401, 70-79.
Poolman EM, Elbasha EH, Galvani AP. - Vaccination and the evolutionary ecology of human papillomavirus. Vaccine, 2008, 26, S25-S30.
McGregor JM, Harwood CA, Brooks L, et al. - Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J Invest Dermatol, 2002, 119, 84-90. (Pubitemid 35304395)
Alamartine E, Berthoux P, Mariat C, et al. - Interleukin- 10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation. J Invest Dermatol, 2003, 120, 99-103. (Pubitemid 36120977)
Tumer TB, Yilmaz D, Tanrikut C, et al. - DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia. Leuk Res, 2010, 34, 1275-1281.
Felley-Bosco E, Weston A, Cawley HM, et al. - Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet, 1993, 53, 752-759. (Pubitemid 23304148)
Li X, Dumont P, Della Pietra A, et al. - The codon 47 polymorphism in p53 is functionally significant. J Biol Chem, 2005, 280, 24245-24251. (Pubitemid 40884914)
Sakamuro D, Sabbatini P, White E, Prendergast GC. - The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene, 1997, 15, 887-898. (Pubitemid 27399550)
Storey A, Thomas M, Kalita A, et al. - Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature, 1998, 393, 229-234. (Pubitemid 28261713)
Cenci M, French D, Pisani T, et al. - p53 polymorphism at codon 72 is not a risk factor for cervical carcinogenesis in central Italy. Anticancer Res, 2003, 23, 1385-1387. (Pubitemid 36754103)
Trimble CL, Piantadosi S, Gravitt P, et al. - Spontaneous regression of high-grade cervical dysplasia : effects of human papillomavirus type and HLA phenotype. Clin Cancer Res, 2005, 11, 4717-4723. (Pubitemid 41557190)
Hengge UR, Emmert S. - Clinical features of xeroderma pigmentosum. Adv Exp Med Biol, 2008, 637, 10-18.
Struijk L, Hall L, van der Meijden E, et al. - Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 2006, 15, 529-535.
Feltkamp MC, Broer R, Di Summa FM, et al. - Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res, 2003, 63, 2695-2700. (Pubitemid 36605215)
Hengge UR. - Role of viruses in the development of squamous cell cancer and melanoma. Adv Exp Med Biol, 2008, 624, 179-186.
Bouwes-Bavinck JN, Euvrard S, Naldi L, et al. - Keratotic skin lesions and other risk factors are associated with skin cancer in organ transplant recipients: a casecontrol study in the Netherlands, United Kingdom, Germany, France and Italy. J Invest Dermatol, 2007, 127, 1647-1656. (Pubitemid 46933435)
Jackson S, Harwood C, Thomas M, et al. - Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 protein. Genes Dev, 2000, 14, 3063-3073.
Campo E, Swerdlow SH, Harris NL, et al. - The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood, 2011, 117, 5019-5032.
Murray PG, Young LS. - Epstein-Barr virus infection: basis of malignancy and potential for therapy. Expert Rev Mol Med, 2001, 3, 1-20.
Carbone A, Gloghini A, Dotti G. - EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist, 2008, 13, 577-585. (Pubitemid 351872874)
Glaser SL, Lin RJ, Stewart SL, et al. - Epstein-Barr virus-associated Hodgkin's disease : epidemiologic characteristics in international data. Int J Cancer, 1997, 70, 375-382. (Pubitemid 27107262)
Küppers R. - B cells under influence : transformation of B cells by Epstein-Barr virus. Nat Rev Immunol, 2003, 3, 801-812.
Re D, Kuppers R, Diehl V. - Molecular pathogenesis of Hodgkin's lymphoma. J Clin Oncol, 2005, 23, 6379-6386.
Végsö G, Hajdu M, Sebestyén A. - Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options. Pathol Oncol Res, 2011, 17, 443-454.
Harris NL, Stein H, Coupland SE, et al. - New approaches to lymphoma diagnosis. Hematology Am Soc Hematol Educ Program, 2001, 194-220.
Piccaluga PP, Agostinelli C, Gazzola A, et al. - Pathobiology of Hodgkin lymphoma. Adv Hematol, 2011, 2011, 920898.
Niens M, Jarrett RF, Hepkema B, et al. - HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. Blood, 2007, 110, 3310-3315. (Pubitemid 350106324)
Cader F, Kearns P, Young L, et al. - The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas. Cancer Treat Rev, 2010, 36, 348-353.
Perrine SP, Hermine O, Small T, et al. - A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood, 2007, 109, 2571-2578. (Pubitemid 46425904)